Cargando…
Addition of apatinib to transarterial chemoembolization leads to improved outcome in patients with intermediate and advanced hepatocellular cancer
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859795/ https://www.ncbi.nlm.nih.gov/pubmed/33553295 http://dx.doi.org/10.21037/atm-20-7534 |
_version_ | 1783646813672177664 |
---|---|
author | Pocha, Pauline Viviane Xie, Chencheng Pocha, Christine |
author_facet | Pocha, Pauline Viviane Xie, Chencheng Pocha, Christine |
author_sort | Pocha, Pauline Viviane |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7859795 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-78597952021-02-05 Addition of apatinib to transarterial chemoembolization leads to improved outcome in patients with intermediate and advanced hepatocellular cancer Pocha, Pauline Viviane Xie, Chencheng Pocha, Christine Ann Transl Med Editorial AME Publishing Company 2021-01 /pmc/articles/PMC7859795/ /pubmed/33553295 http://dx.doi.org/10.21037/atm-20-7534 Text en 2021 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Editorial Pocha, Pauline Viviane Xie, Chencheng Pocha, Christine Addition of apatinib to transarterial chemoembolization leads to improved outcome in patients with intermediate and advanced hepatocellular cancer |
title | Addition of apatinib to transarterial chemoembolization leads to improved outcome in patients with intermediate and advanced hepatocellular cancer |
title_full | Addition of apatinib to transarterial chemoembolization leads to improved outcome in patients with intermediate and advanced hepatocellular cancer |
title_fullStr | Addition of apatinib to transarterial chemoembolization leads to improved outcome in patients with intermediate and advanced hepatocellular cancer |
title_full_unstemmed | Addition of apatinib to transarterial chemoembolization leads to improved outcome in patients with intermediate and advanced hepatocellular cancer |
title_short | Addition of apatinib to transarterial chemoembolization leads to improved outcome in patients with intermediate and advanced hepatocellular cancer |
title_sort | addition of apatinib to transarterial chemoembolization leads to improved outcome in patients with intermediate and advanced hepatocellular cancer |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859795/ https://www.ncbi.nlm.nih.gov/pubmed/33553295 http://dx.doi.org/10.21037/atm-20-7534 |
work_keys_str_mv | AT pochapaulineviviane additionofapatinibtotransarterialchemoembolizationleadstoimprovedoutcomeinpatientswithintermediateandadvancedhepatocellularcancer AT xiechencheng additionofapatinibtotransarterialchemoembolizationleadstoimprovedoutcomeinpatientswithintermediateandadvancedhepatocellularcancer AT pochachristine additionofapatinibtotransarterialchemoembolizationleadstoimprovedoutcomeinpatientswithintermediateandadvancedhepatocellularcancer |